<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/Heart_Attack.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:30:20 GMT -->
<head>
<meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
<meta name="Language" content="es">
<meta name="ContentID" content="1025008">
<meta name="Category" content="Concern">
<meta name="Article" content="Heart_Attack">
<title>Ataque Cardiaco-Referencias</title>
<link type="text/css" rel="stylesheet" href="../Styles/hnqrHtml.css">
<base target="_self">
</head>
<body>
<div id="Article-Title" class="Article-Title"><a name="Article-Title"></a> 

<p class="Article-Title">Ataque Cardiaco</p>
</div>

<div id="Reference-List" class="Reference-List">
<p class="Reference-Autofill"><a href="Heart_Attack.htm">Volver al
art&#237;culo.</a></p>

<h3>Referencias para el art&#237;culo</h3>

<ol class="Reference-List">
<li class="Ref">Hu FB, Stampfer MJ, Manson JE, et al. Dietary fat intake and the risk of
coronary heart disease in women. <em>N Engl J Med</em> 1997;337:1491&#8211;9.</li>

<li class="Ref">Willett WC, Stampfer MJ, Manson JE, et al. Intake of trans fatty acids and
risk of coronary heart disease among women. <em>Lancet</em> 1993;341:581&#8211;5.</li>

<li class="Ref">Gramenzi A, Gentile A, Fasoli M, et al. Association between certain foods and
risk of acute myocardial infarction in women. <em>BMJ</em> 1990;300:771&#8211;3.</li>

<li class="Ref">Hu FB, Stampfer MJ, Manson JE, et al. Frequent nut consumption and risk of
coronary heart disease in women: prospective cohort study. <em>BMJ</em>
1998;317:1341&#8211;5.</li>

<li class="Ref">Fraser GE, Sabat&#233; J, Beeson WL, Strahan TM. A possible protective effect
of nut consumption on risk of coronary heart disease. <em>Arch Intern Med</em>
1992;152:1416&#8211;24.</li>

<li class="Ref">Abbey M, Noakes M, Belling GB, Nestel PJ. Partial replacement of saturated
fatty acids with almonds or walnuts lowers total plasma cholesterol and
low-density-lipoprotein cholesterol. <em>Am J Clin Nutr</em> 1994;59:995&#8211;9.</li>

<li class="Ref">Sabat&#233; J, Frasser GE, Burke K, et al. Effects of walnuts on serum lipid
levels and blood pressure in normal men. <em>N Engl J Med</em> 1993;328:603&#8211;7.</li>

<li class="Ref">Fraser GE. Nut consumption, lipids, and risk of a coronary event. <em>Clin
Cardiol</em> 1999;22(Suppl III):III11&#8211;5 [review].</li>

<li class="Ref">Durak I, K&#246;ksal I, Ka&#231;maz M, et al. Hazelnut supplementation
enhances plasma antioxidant potential and lowers plasma cholesterol levels. <em>Clin Chim
Actia</em> 1999;284:113&#8211;5 [letter].</li>

<li class="Ref">Edwards K, Kwaw I, Matud J, Kurtz I. Effect of pistachio nuts on serum lipid
levels in patients with moderate hypercholesterolemia. <em>J Am Coll Nutr</em>
1999;18:229&#8211;32.</li>

<li class="Ref">Mirkin G. Walnuts and serum lipids. <em>N Engl J Med</em> 1993;329:358
[letter].</li>

<li class="Ref">Mann GV. Walnuts and serum lipids. <em>N Engl J Med</em> 1993;329:358
[letter].</li>

<li class="Ref">Fraser GE, Jaceldo K, Sabat&#233; J, et al. Changes in body weight with a
daily supplement of 340 calories from almonds for six months. <em>FASEB J</em> 1999;13:A539
[abstract].</li>

<li class="Ref">Fraser GE. Nut consumption, lipids, and risk of a coronary event. <em>Clin
Cardiol</em> 1999;22(Suppl III):III11&#8211;5 [review].</li>

<li class="Ref">Durak I, K&#246;ksal I, Ka&#231;maz M, et al. Hazelnut supplementation
enhances plasma antioxidant potential and lowers plasma cholesterol levels. <em>Clin Chim
Actia</em> 1999;284:113&#8211;5 [letter].</li>

<li class="Ref">Daviglus ML, Stamler J, Orencia AJ, et al. Fish consumption and the 30-year
risk of fatal myocardial infarction. <em>N Engl J Med</em> 1997;336:1046&#8211;53.</li>

<li class="Ref">Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and
fibre intakes on death and myocardial reinfarction: diet and reinfarction trial. <em>
Lancet</em> 1989;2:757&#8211;61.</li>

<li class="Ref">Landmark K, Abdelnoor M, Kilhovd B, Dorum HP. Eating fish may reduce infarct
size and the occurrence of Q wave infarcts. <em>Eur J Clin Nutr</em> 1998;52:40&#8211;4.</li>

<li class="Ref">Morris MC, Manson JE, Rosner B, et al. Fish consumption and cardiovascular
disease in the physicians&#8217; health study: a prospective study. <em>Am J Epidemiol</em>
1995;142:166&#8211;75.</li>

<li class="Ref">Von Schacky C, Angerer P, Kothney W, et al. The effect of dietary omega-3
fatty acids on coronary atherosclerosis. A randomized double-blind, placebo-controlled trial.
<em>Ann Intern Med</em> 1999;130:554&#8211;62.</li>

<li class="Ref">Shekelle RB, Stamler J. Dietary cholesterol and ischaemic heart disease. <em>
Lancet</em> 1989;1:1177&#8211;9.</li>

<li class="Ref">Hu FB, Stampfer MJ, Rimm EB, et al. A prospective study of egg consumption and
risk of cardiovascular disease in men and women. <em>JAMA</em> 1999;281:1387&#8211;94.</li>

<li class="Ref">Raloff J. Oxidized lipids: a key to heart disease? <em>Sci News</em>
1985;127:278.</li>

<li class="Ref">Levy Y, Maor I, Presser D, Aviram M. Consumption of eggs with meals increases
the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. <em>Ann
Nutr Metabol</em> 1996;40:243&#8211;51.</li>

<li class="Ref">Liu S, Willett WC, Stampfer MJ, et al. A prospective study of dietary glycemic
load, carbohydrate intake, and risk of coronary heart disease in US women. <em>Am J Clin
Nutr</em> 2000;71:1455&#8211;61.</li>

<li class="Ref">Pietinen P, Rimm EB, Korhonen P, et al. Intake of dietary fiber and risk of
coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene
Prevention Study. <em>Circulation</em> 1996;94:2720&#8211;7.</li>

<li class="Ref">Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of
dietary fiber: a meta-analysis. <em>Am J Clin Nutr</em> 1999;69:30&#8211;42.</li>

<li class="Ref">Rimm EB, Ascherio A, Giovannucci E, et al. Vegetable, fruit, and cereal fiber
intake and risk of coronary heart disease among men. <em>JAMA</em> 1996;275:447&#8211;51.</li>

<li class="Ref">Wolk A, Manson JE, Stampfer MJ, et al. Long-term intake of dietary fiber and
decreased risk of coronary heart disease among women. <em>JAMA</em>
1999;281:1998&#8211;2004.</li>

<li class="Ref">Strandhagen E, Hansson PO, Bosaeus I, et al. High fruit intake may reduce
mortality among middle-aged and elderly men. The Study of Men Born in 1913. <em>Eur J Clin
Nutr</em> 2000;54:337&#8211;41.</li>

<li class="Ref">Singh RB, Rastogi SS, Verma R, et al. An Indian experiment with nutritional
modulation in acute myocardial infarction. <em>Am J Cardiol</em> 1992;69:879&#8211;85.</li>

<li class="Ref">Singh RB, Niaz MA, Ghosh S, et al. Effect on mortality and reinfarction of
adding fruits and vegetables to a prudent diet in the Indian Experiment of Infarct Survival
(IEIS). <em>J Am Coll Nutr</em> 1993;12:255&#8211;61.</li>

<li class="Ref">Gramenzi A, Gentile A, Fasoli M, et al. Association between certain foods and
risk of acute myocardial infarction in women. <em>BMJ</em> 1990;300:771&#8211;3.</li>

<li class="Ref">Hu FB, Stampfer MJ, Manson JE, et al. Frequent nut consumption and risk of
coronary heart disease in women: prospective cohort study. <em>BMJ</em>
1998;317:1341&#8211;5.</li>

<li class="Ref">de Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean alpha-linolenic
acid-rich diet in secondary prevention of coronary heart disease. <em>Lancet</em>
1994;343:1454&#8211;9.</li>

<li class="Ref">de Lorgeril M, Salen P, Martin JL, et al. Mediterranean diet, traditional risk
factors, and the rate of cardiovascular complications after myocardial infarction: final
report of the Lyon Diet Heart Study. <em>Circulation</em> 1999;99:779&#8211;85.</li>

<li class="Ref">Rice RD. Mediterranean diet. <em>Lancet</em> 1994;344:893&#8211;4
[letter].</li>

<li class="Ref">Rosenberg L, Slone D, Shapiro S, et al. Alcoholic beverages and myocardial
infarction in young women. <em>Am J Public Health</em> 1981;71:82&#8211;5.</li>

<li class="Ref">Kono S, Handa K, Kawano T, et al. Alcohol intake and nonfatal acute myocardial
infarction in Japan. <em>Am J Cardiol</em> 1991;68:1011&#8211;4.</li>

<li class="Ref">Jackson R, Scragg R, Beaglehole R. Does recent alcohol consumption reduce the
risk of acute myocardial infarction and coronary death in regular drinkers? <em>Am J
Epidemiol</em> 1992;136:819&#8211;24.</li>

<li class="Ref">Hammar N, Romelsjo A, Alfredsson L. Alcohol consumption, drinking pattern and
acute myocardial infarction. A case referent study based on the Swedish Twin Register. <em>J
Intern Med</em> 1997;241:125&#8211;31.</li>

<li class="Ref">Bianchi C, Negri E, La Vecchia C, Franceschi S. Alcohol consumption and the
risk of acute myocardial infarction in women. <em>J Epidemiol Community Health</em>
1993;47:308&#8211;11.</li>

<li class="Ref">Gaziano JM, Hennekens CH, Godfried SL, et al. Type of alcoholic beverage and
risk of myocardial infarction. <em>Am J Cardiol</em> 1999;83:52&#8211;7.</li>

<li class="Ref">Hart CL, Smith GD, Hole DJ, Hawthorne VM. Alcohol consumption and mortality
from all causes, coronary heart disease, and stroke: results from a prospective cohort study
of Scottish men with 21 years of follow up. <em>BMJ</em> 1999;318:1725&#8211;9.</li>

<li class="Ref">Law M, Wald N. Why heart disease mortality is low in France: the time lag
explanation. <em>BMJ</em> 1999;318:1471&#8211;80 [review].</li>

<li class="Ref">Gaziano JM, Hennekens CH, Godfried SL, et al. Type of alcoholic beverage and
risk of myocardial infarction. <em>Am J Cardiol</em> 1999;83:52&#8211;7.</li>

<li class="Ref">Gaziano JM, Buring JE, Breslow JL, et al. Moderate alcohol intake, increased
levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial
infarction. <em>N Engl J Med</em> 1993;329:1829&#8211;34.</li>

<li class="Ref">Renaud S, de Lorgeril M. Wine, alcohol, platelets and the French paradox for
coronary heart disease. <em>Lancet</em> 1992;339:1523&#8211;6.</li>

<li class="Ref">Sharpe PC, McGrath LT, McClean E, et al. Effect of red wine consumption on
lipoprotein (a) and other risk factors for atherosclerosis. <em>Q J Med</em>
1995;88:101&#8211;8.</li>

<li class="Ref">Holman CDJ, English DR, Milne E, Winter MG. Meta-analysis of alcohol and
all-cause mortality: a validation of NHMRC recommendations. <em>Med J Aust</em>
1996;64:141&#8211;5.</li>

<li class="Ref">Rosenberg L, Palmer JR, Kelly JP, et al. Coffee drinking and nonfatal
myocardial infarction in men under 55 years of age. <em>Am J Epidemiol</em>
1988;128:570&#8211;8.</li>

<li class="Ref">Palmer JR, Rosenberg L, Rao RS, Shapiro S. Coffee consumption and myocardial
infarction in women. <em>Am J Epidemiol</em> 1995;141:724&#8211;31.</li>

<li class="Ref">Greenland S. A meta-analysis of coffee, myocardial infarction, and coronary
death. <em>Epidemiology</em> 1993;4:366&#8211;74.</li>

<li class="Ref">Myers MG, Basinski A. Coffee and coronary heart disease. <em>Arch Intern
Med</em> 1992;152:1767&#8211;2.</li>

<li class="Ref">Stolzenberg-Solomon RZ, Miller ER 3rd, Maquire MG, et al. Association of
dietary protein intake and coffee consumption with serum homocysteine concentrations in an
older population. <em>Am J Clin Nutr</em> 1999;69:467&#8211;75.</li>

<li class="Ref">Nyg&#229;rd O, Refsum H, Velanb PM, et al. Coffee consumption and plasma total
homocysteine: The Hordaland Homocysteine Study. <em>Am J Clin Nutr</em>
1997;65:136&#8211;43.</li>

<li class="Ref">He J, Ogden LG, Vupputuri S, et al. Dietary sodium intake and subsequent risk
of cardiovascular disease in overweight adults. <em>JAMA</em> 1999;282:2027&#8211;34.</li>

<li class="Ref">Yudkin J, Morland J. Sugar intake and myocardial infarction. <em>Am J Clin
Nutr</em> 1967;20:503&#8211;6.</li>

<li class="Ref">Platt L, Ball KP, Brigden WW, et al. Dietary sugar intake in men with
myocardial infarction. <em>Lancet</em> 1970 Dec 19;2:1265&#8211;71.</li>

<li class="Ref">Yudkin J, Kang SS, Bruckdorfer KR. Effects of high dietary sugar. <em>Br Med
J</em> 1980;281:1396.</li>

<li class="Ref">Albrink MJ, Ullrich IH. Interaction of dietary sucrose and fiber on serum
lipids in healthy young men fed high carbohydrate diets. <em>Am J Clin Nutr</em>
1986;43:419&#8211;28.</li>

<li class="Ref">Reiser S. Effect of dietary sugars on metabolic risk factors associated with
heart disease. <em>Nutr Health</em> 1985;3:203&#8211;16.</li>

<li class="Ref">Liu K, Stamler J, Trevisan M, Moss D. Dietary lipids, sugar, fiber, and
mortality from coronary heart disease. Bivariate analysis of international data. <em>
Arteriosclerosis</em> 1982;2:221&#8211;7.</li>

<li class="Ref">Prescott E, Hippe M, Schnohr P, et al. Smoking and risk of myocardial
infarction in women and men: longitudinal population study. <em>BMJ</em>
1998;316:1043&#8211;7.</li>

<li class="Ref">Nyboe J, Jensen G, Appleyard M, Schnohr P. Smoking and the risk of first acute
myocardial infarction. <em>Am Heart J</em> 1991;122:438&#8211;47.</li>

<li class="Ref">Rosenberg L, Palmer JR, Shapiro S. Decline in the risk of myocardial
infarction among women who stop smoking. <em>N Engl J Med</em> 1990;322:213&#8211;7.</li>

<li class="Ref">Zhu B, Sun Y, Sievers RE, et al. Exposure to environmental tobacco smoke
increases myocardial infarct size in rats. <em>Circulation</em> 1994;89:1282&#8211;90.</li>

<li class="Ref">Zhu B, Parmley WW. Hemodynamic and vascular effects of active and passive
smoking. <em>Am Heart J</em> 1995;130:1270&#8211;5 [review].</li>

<li class="Ref">Wilson K, Gibson N, Willan A, Cook D. Effect of smoking cessation on mortality
after myocardial infarction: meta-analysis of cohort studies. <em>Arch Intern Med</em>
2000;160:939&#8211;44.</li>

<li class="Ref">Mittleman MA, Maclure M, Tofler GH, et al. Triggering of acute myocardial
infarction by heavy physical exertion. Protection against triggering by regular exertion.
Determinants of Myocardial Infarction Onset Study Investigators. <em>N Engl J Med</em>
1993;329:1677&#8211;83.</li>

<li class="Ref">Willich SN, Lewis M, Lowel H, et al. Physical exertion as a trigger of acute
myocardial infarction. Triggers and Mechanisms of Myocardial Infarction Study Group. <em>N
Engl J Med</em> 1993;329:1684&#8211;90.</li>

<li class="Ref">Mittleman MA, Siscovick DS. Physical exertion as a trigger of myocardial
infarction and sudden cardiac death. <em>Cardiol Clin</em> 1996;14:263&#8211;70 [review].</li>

<li class="Ref">Muller JE, Mittleman A, Maclure M, et al. Triggering myocardial infarction by
sexual activity. Low absolute risk and prevention by regular physical exertion. Determinants
of Myocardial Infarction Onset Study Investigators. <em>JAMA</em> 1996;275:1405&#8211;9.</li>

<li class="Ref">Schargrodsky H, Rozlosnik J, Ciruzzi M, et al. Body weight and nonfatal
myocardial infarction in a case-control study from Argentina. <em>Soz Praventivmed</em>
1994;39:126&#8211;33.</li>

<li class="Ref">Tavani A, Negri E, D&#8217;Avanzo B, La Vecchia C. Body weight and risk of
nonfatal acute myocardial infarction among women: a case-control study from northern Italy.
<em>Prev Med</em> 1997;26:550&#8211;5.</li>

<li class="Ref">Kawachi I, Sparrow D, Kubzansky LD, et al. Prospective study of a self-report
type A scale and risk of coronary heart disease: test of the MMPI-2 type A scale. <em>
Circulation</em> 1998;98:405&#8211;12.</li>

<li class="Ref">Raymond C. Distrust, rage may be &#8216;toxic core&#8217; that puts
&#8216;type A&#8217; person at risk. <em>JAMA</em> 1989;261:813.</li>

<li class="Ref">Dimsdale JE. A perspective on type A behavior and coronary disease. <em>N Engl
J Med</em> 1988;318:110&#8211;2 [editorial].</li>

<li class="Ref">Friedman M, Thoresen CE, Gill JJ, et al. Alteration of type A behavior and
reduction in cardiac recurrences in postmyocardial infarction patients. <em>Am Heart J</em>
1984;108:237&#8211;48.</li>

<li class="Ref">Kawachi I, Sparrow D, Spiro A 3rd, et al. A prospective study of anger and
coronary heart disease. The Normative Aging Study. <em>Circulation</em>
1996;94:2090&#8211;5.</li>

<li class="Ref">Kubzansky LD, Kawachi I, Spiro A 3rd, et al. Is worrying bad for your heart? A
prospective study of worry and coronary heart disease in the Normative Aging Study. <em>
Circulation</em> 1997;95:818&#8211;24.</li>

<li class="Ref">Hammar N, Alfredsson L, Johnson JV. Job strain, social support at work, and
incidence of myocardial infarction. <em>Occup Environ Med</em> 1998;55:548&#8211;53.</li>

<li class="Ref">Knox SS, Adelman A, Ellison RC, et al. Hostility, social support, and carotid
artery atherosclerosis in the National Heart, Lung, and Blood Institute Family Heart Study.
<em>Am J Cardiol</em> 2000;86:1086&#8211;9.</li>

<li class="Ref">Knox SS, Siegmund KD, Weidner G, et al. Hostility, social support, and
coronary heart disease in the National Heart, Lung, and Blood Institute Family Heart Study.
<em>Am J Cardiol</em> 1998;82:1192&#8211;6.</li>

<li class="Ref">Orth-Gomer K, Wamala SP, Horsten M, et al. Marital stress worsens prognosis in
women with coronary heart disease: the Stockholm female coronary risk study. <em>JAMA</em>
2000;284:3008&#8211;14.</li>

<li class="Ref">Allen C, Glasziou P, Del Mar C. Bed rest: a potentially harmful treatment
needing more careful evaluation. <em>Lancet</em> 1999;354:1229&#8211;33 [review].</li>

<li class="Ref">Davini P, Bigalli A, Lamanna F, Boem A. Controlled study on L-carnitine
therapeutic efficacy in post-infarction. <em>Drugs Exp Clin Res</em>
1992;18:355&#8211;65.</li>

<li class="Ref">De Pasquale B, Righetti G, Menotti A. L-carnitine for the treatment of acute
myocardial infarct. <em>Cardiologia</em> 1990;35:591&#8211;6 [in Italian].</li>

<li class="Ref">Iliceto S, Scrutinio D, Bruzzi P, et al. Effects of L-carnitine administration
on left ventricular remodeling after acute anterior. <em>J Am Coll Cardiol</em>
1995;26:380&#8211;7.</li>

<li class="Ref">Singh RB, Niaz MA, Agarwal P, et al. A randomised double-blind
placebo-controlled trial of L-carnitine in suspected acute myocardial infarction. <em>Postgrad
Med J</em> 1996;72:45&#8211;50.</li>

<li class="Ref">Martina B, Zuber M, Weiss P, et al. Anti-arrhythmia treatment using
L-carnitine in acute myocardial infarct. <em>Schweiz Med Wochenschr</em> 1992;122:1352&#8211;5
[in German].</li>

<li class="Ref">Chambers JC, McGergor A, Jean-Marie J, et al. Demonstration of rapid onset
vascular endothelial dysfunction after hyperhomocysteinemia. An effect reversible with vitamin
C therapy. <em>Circulation</em> 1999;99:1156&#8211;60.</li>

<li class="Ref">Fuller CJ, Grundy SM, Norkus EP, Jialal I. Effect of ascorbate supplementation
on low density lipoprotein oxidation in smokers. <em>Atherosclerosis</em>
1996;119:139&#8211;50.</li>

<li class="Ref">Rath M, Pauling L. Solution to the puzzle of human cardiovascular disease: Its
primary cause is ascorbate deficiency leading to the deposition of lipoprotein (a) and
fibrinogen/fibrin in the vascular wall. <em>J Orthomol Med</em> 1992;6:125&#8211;34.</li>

<li class="Ref">Manson JE, Stampfer MJ, Willett WC, et al. A prospective study of vitamin C
and incidence of coronary heart disease in women. <em>Circulation</em> 1992;85:865
[abstract].</li>

<li class="Ref">Klipstein-Grobusch K, Geleijnse JM, den Breeijen JH, et al. Dietary
antioxidants and risk of myocardial infarction in the elderly: the Rotterdam Study. <em>Am J
Clin Nutr</em> 1999;69:261&#8211;6.</li>

<li class="Ref">Nyyss&#246;nen K, Parvianinen MT, Salonen R, et al. Vitamin C deficiency and
risk of myocardial infarction: prospective population study of men from eastern Finland. <em>
BMJ</em> 1997;314:634&#8211;8.</li>

<li class="Ref">Simon JA, Hudes ES, Browner WS. Serum ascorbic acid and cardiovascular disease
prevalence in U.S. adults. <em>Epidemiology</em> 1998;9:316&#8211;21.</li>

<li class="Ref">Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of
coronary heart disease in men. <em>N Engl J Med</em> 1993;328:1450&#8211;6.</li>

<li class="Ref">Singh RB, Niaz MA. Serum concentration of lipoprotein (a) decreases on
treatment with hydrosoluble coenzyme Q10 in patients with coronary artery disease: discovery
of a new role. <em>Int J Cardiol</em> 1999;68:23&#8211;9.</li>

<li class="Ref">Atar D, Mortensen SA, Flachs H, Herzog WR. Coenzyme Q10 protects ischemic
myocardium in an open-chest swine model. <em>Clin Investig</em> 1993;71:S103&#8211;11.</li>

<li class="Ref">Ishikura Y, Odagiri S, Nagata M, et al. Effects of coenzyme Q10 on ischemic
myocardium during coronary artery occlusion&#8212;evaluation of the time needed to change
irreversible myocardium. <em>Sangyo Ika Daigaku Zasshi</em> 1986;8:19&#8211;25 [in
Japanese].</li>

<li class="Ref">Singh RB, Wander GS, Rastogi A, et al. Randomized double-blind
placebo-controlled trial of coenzyme Q10 in patients with acute myocardial infarction. <em>
Cardiovasc Drugs Ther</em> 1998;12:347&#8211;53.</li>

<li class="Ref">Kuklinski B, Weissenbacher E, Fahnrich A. Coenzyme Q10 and antioxidants in
acute myocardial infarction. <em>Mol Aspects Med</em> 1994;15 Suppl:s143&#8211;7.</li>

<li class="Ref">Auzepy P, Blondeau M, Richard C, et al. Serum selenium deficiency in
myocardial infarction and congestive cardiomyopathy. <em>Acta Cardiol</em>
1987;42:161&#8211;6.</li>

<li class="Ref">Oster O, Drexler M, Schenk J, et al. The serum selenium concentration of
patients with acute myocardial infarction. <em>Ann Clin Res</em> 1986;18:36&#8211;42.</li>

<li class="Ref">Beaglehole R, Jackson R, Watkinson J, et al. Decreased blood selenium and risk
of myocardial infarction. <em>Int J Epidemiol</em> 1990;19:918&#8211;22.</li>

<li class="Ref">Kardinaal AFM, Kok FJ, Kohlmeier L, et al. Association between toenail
selenium and risk of acute myocardial infarction in European men. <em>Am J Epidemiol</em>
1997;145:373&#8211;9.</li>

<li class="Ref">Salvini S, Hennekenes CH, Morris JS, et al. Plasma levels of the antioxidant
selenium and risk of myocardial infarction among U.S. physicians. <em>Am J Cardiol</em>
1995;76:1218&#8211;21.</li>

<li class="Ref">Korpela H, Kumpulainen J, Jussila E, et al. Effect of selenium supplementation
after acute myocardial infarction. <em>Res Commun Chem Pathol Pharmacol</em>
1989;65:249&#8211;52.</li>

<li class="Ref">Kuklinski B, Weissenbacher E, Fahnrich A. Coenzyme Q10 and antioxidants in
acute myocardial infarction. <em>Mol Aspects Med</em> 1994;15 Suppl:s143&#8211;7.</li>

<li class="Ref">Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of
coronary heart disease in men. <em>N Engl J Med</em> 1993;328:1450&#8211;6.</li>

<li class="Ref">Stampfer MJ, Hennekens CH, Manson JE, et al. Vitamin E consumption and the
risk of coronary heart disease in women. <em>N Engl J Med</em> 1993;328:1444&#8211;9.</li>

<li class="Ref">Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of
vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). <em>
Lancet</em> 1996;347:781&#8211;6.</li>

<li class="Ref">Boaz M, Smetana S, Weinstein T, et al. Secondary prevention with antioxidants
of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled
trial. <em>Lancet</em> 2000;356:1213&#8211;8.</li>

<li class="Ref">[No authors listed]. Dietary supplementation with n-3 polyunsaturated fatty
acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial.
Gruppo Italiano per lo Studio della Sopravvivenza nell&#8217;Infarto miocardico. <em>
Lancet</em> 1999;354:447&#8211;55.</li>

<li class="Ref">Collaborative Group of the Primary Prevention Project (PPP). Low-dose aspirin
and vitamin E in people at cardiovascular risk: a randomized trial in general practice. <em>
Lancet</em> 2001;357:89&#8211;95.</li>

<li class="Ref">Yusuf S, Dagenais G, Pogue J, et al. Vitamin E supplementation and
cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study
Investigators. <em>N Engl J Med</em> 2000;342:154&#8211;60.</li>

<li class="Ref">Sochman J, Vrbska J, Musilova B, Rocek M. Infarct Size Limitation: acute
N-acetylcysteine defense (ISLAND trial): preliminary analysis and report after the first 30
patients. <em>Clin Cardiol</em> 1996;19:94&#8211;100.</li>

<li class="Ref">Von Schacky C, Angerer P, Kothney W, et al. The effect of dietary omega-3
fatty acids on coronary atherosclerosis. A randomized double-blind, placebo-controlled trial.
<em>Ann Intern Med</em> 1999;130:554&#8211;62.</li>

<li class="Ref">Singh RB, Niaz MA, Sharma JP, et al. Randomized, double-blind,
placebo-controlled trial of fish oil and mustard oil in patients with suspected acute
myocardial infarction: the Indian experiment of infarct survival--4. <em>Cardiovasc Drugs</em>
1997;11:485&#8211;91.</li>

<li class="Ref">[No authors listed]. Dietary supplementation with n-3 polyunsaturated fatty
acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial.
Gruppo Italiano per lo Studio della Sopravvivenza nell&#8217;Infarto miocardico. <em>
Lancet</em> 1999;354:447&#8211;55.</li>

<li class="Ref">Landmark K, Abdelnoor M, Urdal P, et al. Use of fish oils appears to reduce
infarct size as estimated from peak creatine kinase and lactate dehydrogenase activities. <em>
Cardiology</em> 1998;89:94&#8211;102.</li>

<li class="Ref">Wander RC, Du SH, Ketchum SO, Rowe KE. Alpha-tocopherol influences in vivo
indices of lipid peroxidation in postmenopausal women given fish oil. <em>J Nutr</em>
1996;126:643&#8211;52.</li>

<li class="Ref">Singh RB, Niaz MA, Sharma JP, et al. Plasma levels of antioxidant vitamins and
oxidative stress in patients with acute myocardial infarction. <em>Acta Cardiol</em>
1994;49:441&#8211;52.</li>

<li class="Ref">Levy Y, Bartha P, Ben-Amotz A, et al. Plasma antioxidants and lipid
peroxidation in acute myocardial infarction and thrombolysis. <em>J Am Coll Nutr</em>
1998;17:337&#8211;41.</li>

<li class="Ref">Singh RB, Niaz MA, Rastogi SS, Tastogi S. Usefulness of antioxidant vitamins
in suspected acute myocardial infarction (the Indian experiment of infarct survival-3). <em>Am
J Cardiol</em> 1996;77:232&#8211;6.</li>

<li class="Ref">Singh RB, Rastogi SS, Ghosh S, Niaz MA. Dietary and serum magnesium levels in
patients with acute myocardial infarction, coronary artery disease and noncardiac diagnoses.
<em>J Am Coll Nutr</em> 1994;13:139&#8211;43.</li>

<li class="Ref">Hampton EM, Whang DD, Whang R. Intravenous magnesium therapy in acute
myocardial infarction. <em>Ann Pharmacother</em> 1994;28:212&#8211;9 [review].</li>

<li class="Ref">[No authors listed]. ISIS-4: a randomised factorial trial assessing early oral
captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with
suspected acute myocardial infarction. <em>Lancet</em> 1995;345:669&#8211;85.</li>

<li class="Ref">Seelig MS, Elin RJ. Is there a place for magnesium in the treatment of acute
myocardial infarction? <em>Am Heart J</em> 1996;132:471&#8211;7.</li>

<li class="Ref">Marx A, Neutra RR. Magnesium in drinking water and ischemic heart disease.
<em>Epidemiol Rev</em> 1997;19:258&#8211;72.</li>

<li class="Ref">Rubenowitz E, Molin I, Axelsson G, Rylander R. Magnesium in drinking water in
relation to morbidity and mortality from acute myocardial infarction. <em>Epidemiology</em>
2000;11:416&#8211;21.</li>

<li class="Ref">Galloe AM, Rasmussen HS, Jorgensen LN, et al. Influence of oral magnesium
supplementation on cardiac events among survivors of an acute myocardial infarction. <em>
BMJ</em> 1993;307:585&#8211;7.</li>

<li class="Ref">Singh RB, Singh NK, Niaz MA, Sharma JP. Effect of treatment with magnesium and
potassium on mortality and reinfarction of patients with suspected acute myocardial
infarction. <em>Int J Clin Pharmacol Ther</em> 1996;34:219&#8211;25.</li>

<li class="Ref">Singh RB. Effect of dietary magnesium supplementation in the prevention of
coronary heart disease and sudden cardiac death. <em>Magnesium Trace Elem</em>
1990;9:143&#8211;51.</li>

<li class="Ref">Israelsson B, Brattstrom LE, Hultberg BL. Homocysteine and myocardial
infarction. <em>Atherosclerosis</em> 1988;71:227&#8211;33.</li>

<li class="Ref">Ridker PM, Manson JE, Buring JE, et al. Homocysteine and risk of
cardiovascular disease among postmenopausal women. <em>JAMA</em> 1999;281:1817&#8211;21.</li>

<li class="Ref">Bots ML, Launer LJ, Lindemans J, et al. Homocysteine and short-term risk of
myocardial infarction and stroke in the elderly: the Rotterdam Study. <em>Arch Intern Med</em>
1999;159:38&#8211;44.</li>

<li class="Ref">Stampfer MJ, Malinow MR, Willett WC, et al. A prospective study of plasma
homocysteine and risk of myocardial infarction in US physicians. <em>JAMA</em>
1992;268:877&#8211;81.</li>

<li class="Ref">Folsom AR, Nieto FJ, McGovern PG, et al. Prospective study of coronary heart
disease incidence in relation to fasting total homocysteine, related genetic polymorphisms,
and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. <em>Circulation</em>
1998;98:204&#8211;10.</li>

<li class="Ref">Kuller LH, Evans RW. Homocysteine, vitamins, and cardiovascular disease. <em>
Circulation</em> 1998;98:196&#8211;9 [editorial/review].</li>

<li class="Ref">Nallamothu BK, Fendrick AM, Rubenfire M, et al. Potential clinical and
economic effects of homocyst(e)ine lowering. <em>Arch Intern Med</em>
2000;160:3406&#8211;12.</li>

<li class="Ref">Landgren F, Israelsson B, Lindgren A, et al. Plasma homocysteine in acute
myocardial infarction: homocysteine-lowering effect of folic acid. <em>J Intern Med</em>
1995;237:381&#8211;8.</li>

<li class="Ref">Ward M, McNulty H, McPartlin J, et al. Plasma homocysteine, a risk factor for
cardiovascular disease, is lowered by physiological doses of folic acid. <em>QJM</em>
1997;90:519&#8211;24.</li>

<li class="Ref">Lobo A, Naso A, Arheart K, et al. Reduction of homocysteine levels in coronary
artery disease by low-dose folic acid combined with vitamins B6 and B12. <em>Am J Cardiol</em>
1999;83:821&#8211;5.</li>

<li class="Ref">Voutilainen S, Lakka TA, Porkkala-Sarataho E, et al. Low serum folate
concentrations are associated with an excess incidence of acute coronary events: the Kuopio
Ischaemic Heart Disease Risk Factor Study. <em>Eur J Clin Nutr</em> 2000;54:424&#8211;8.</li>

<li class="Ref">Kardinaal AFM, Kok FJ, Ringstad J, et al. Antioxidants in adipose tissue and
risk of myocardial infarction: the EURAMIC study. <em>Lancet</em> 1993;342:1379&#8211;84.</li>

<li class="Ref">Tavani A, Negri E, D&#8217;Avanzo B, La Vecchia C. Beta-carotene intake and
risk of nonfatal acute myocardial infarction in women. <em>Eur J Epidemiol</em>
1997;13:631&#8211;7.</li>

<li class="Ref">Rapola JM, Virtamo J, Ripatti S, et al. Randomised trial of alpha-tocopherol
and beta-carotene supplements on incidence of major coronary events in men with previous
myocardial infarction. <em>Lancet</em> 1997;349:1715&#8211;20.</li>

<li class="Ref">Virtamo J, Rapola JM, Ripatti S, et al. Effect of vitamin E and beta carotene
on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease.
<em>Arch Intern Med</em> 1998;158:668&#8211;75.</li>

<li class="Ref">Klipstein-Grobusch K, Geleijnse JM, den Breeijen JH, et al. Dietary
antioxidants and risk of myocardial infarction in the elderly: the Rotterdam Study. <em>Am J
Clin Nutr</em> 1999;69:261&#8211;6.</li>

<li class="Ref">Morrison LM, Branwood AW, Ershoff BH, et al. The prevention of coronary
arteriosclerotic heart disease with chondroitin sulfate A: Preliminary report. <em>Exp Med
Surg</em> 1969;27:278&#8211;89.</li>

<li class="Ref">Morrison LM. Reduction of ischemic coronary heart disease by chondroitin
sulfate. <em>Angiology</em> 1971;22:165&#8211;74.</li>

<li class="Ref">Morrison LM, Enrick NL. Coronary heart disease: Reduction of death rate by
chondroitin sulfate A<em>. Angiology</em> 1973;24:269&#8211;82.</li>

<li class="Ref">Linden V. Vitamin D and myocardial infarction. <em>BMJ</em>
1974;3:647&#8211;50.</li>

<li class="Ref">Vik B, Try K, Thelle DS, Forde OH. Tr&#248;mso Heart Study: vitamin D
metabolism and myocardial infarction. <em>Br Med J</em> 1979;2:176.</li>

<li class="Ref">Arad Y, Spadaro LA, Roth M, et al. Serum concentration of calcium, 1,25
vitamin D and parathyroid hormone are not correlated with coronary calcifications. An electron
beam computed tomography study. <em>Coron Artery Dis</em> 1998;9:513&#8211;8.</li>

<li class="Ref">Watson KE, Abrolat ML, Malone LL, et al. Active serum vitamin D levels are
inversely correlated with coronary calcification. <em>Circulation</em>
1997;96:1755&#8211;60.</li>

<li class="Ref">Lind L, Skarfors E, Berglund L, et al. Serum calcium: a new, independent,
prospective risk factor for myocardial infarction in middle-aged men followed for 18 years.
<em>J Clin Epidemiol</em> 1997;50:967&#8211;73.</li>

<li class="Ref">Myrup B, Hensen GF, McNair P. Cardiovascular risk factors during
estrogen-norethindrone and cholecalciferol treatment. <em>Arch Intern Med</em>
1992;152:2265&#8211;8.</li>

<li class="Ref">Heikkinen AM, Tuppurainen MT, Niskanen L, et al. Long-term vitamin D3
supplementation may have adverse effects on serum lipids during postmenopausal hormone
replacement therapy. <em>Eur J Endocrinol</em> 1997;137:495&#8211;502.</li>

<li class="Ref">Danesh J, Appleby P. Coronary heart disease and iron status. Meta-analyses of
prospective studies. <em>Circulation</em> 1999;99:852&#8211;4.</li>

<li class="Ref">Chen LX, Liao JZ, Guo WQ. Effects of Astragalus membranaceus on left
ventricular function and oxygen free radical in acute myocardial infarction patients and
mechanism of its cardiotonic action. <em>Chung Kuo Chung His I Chieh Ho Tsa Chih</em>
1995;15:141&#8211;3 [in Chinese].</li>

<li class="Ref">Shi HM, Dai RH, Wang SY. Primary research on the clinical significance of
ventricular late potentials (VLPs), and the impact of mexiletine, lidocaine and Astragalus
membranaceus on VLPs. <em>Chung His I Chieh Ho Tsa Chih</em> 1991;11:259, 265&#8211;7 [in
Chinese].</li>
</ol>
</div>
</body>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/Heart_Attack.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:30:20 GMT -->
</html>

